Avicel®

Avicel® CL - 611 a non-animal-origin ingredient, is used in sprays and suspensions. It's compatible with various manufacturing methods like direct compression, dry granulation, and wet granulation. In pharmaceuticals, it acts as a binder, filler, stabilizer, and immediate release agent. It's also an emulsifying agent and viscosity modifier, aiding suspension.

Avicel® DG derived from non-animal sources, is a versatile powder used in tablet manufacturing. Its chemical composition includes calcium, hydrogen phosphate, cellulose, and cellulosics. Employing direct compression or wet granulation techniques, it functions as a binder and compression aid in tablet formulations.

Microcrystalline Cellulose is purified, partially depolymerized cellulose prepared by treating alpha cellulose obtained as a pulp from fibrous plant material with mineral acids. Several grades of Avicel® PH MCC are available varying in particle size distribution, density and moisture content. Avicel® PH microcrystalline cellulose (MCC) is most often used as a compression Aid, filler, flow aid, and dry binder for tablets and capsules. Avicel® PH-101 has a typical average particle size of 50 µm and moisture content between 3 and 5%. Avicel® PH-101 is primarily used for wet granulation, extrusion spherization and tablet compression. Avicel® PH MCC rapidly absorbs aqueous binder solution permitting faster addition of fluid as well as shorter wet massing time. At the same time, the water does not become bound water resulting in faster drying time and uniform granular properties.

Avicel® PH - 102SCG is a microcrystalline cellulose used in direct compression, dry granulation, and wet granulation manufacturing technologies. It is essential for producing high-quality pharmaceutical tablets with optimal stability and performance.

Avicel® PH - 103 is a microcrystalline cellulose used in direct compression, dry granulation, and wet granulation technologies. It serves the healthcare and pharma markets, particularly in oral drug delivery and care solutions. This product is available in granule form.

Avicel® PH - 112 is used in direct compression, dry granulation, and wet granulation applications. It is caffeine-free, CMR substance-free, diethylene glycol-free, and dioxane-free, ensuring safe and effective pharmaceutical formulations.

Avicel® PH - 113 composed of microcrystalline cellulose, finds application in tablet formulations. Manufactured using direct compression, dry granulation, and wet granulation techniques, it serves as a binder and compression aid. Derived from non-animal sources, it meets pharmaceutical and nutraceutical standards.

Avicel® PH - 200 composed of microcrystalline cellulose, finds application in tablet formulations. Manufactured using direct compression, dry granulation, and wet granulation techniques, it serves as a binder and compression aid. Derived from non-animal sources, it meets pharmaceutical and nutraceutical standards.

Avicel® PH - 301 is a multifunctional ingredient utilised in various pharmaceutical applications, including granules, suspensions, and tablets. It acts as a binder, compression aid, filler, and immediate release agent, streamlining the manufacturing process and ensuring consistent product quality. This versatile component enhances formulation efficiency and contributes to the development of high-performance pharmaceutical products.

Avicel® PH - 302 identified as microcrystalline cellulose, is a cornerstone in pharmaceutical applications such as granules, suspensions, and tablets. Its versatility encompasses direct compression, dry granulation, and wet granulation processes. Functioning as a binder, compression aid, filler, and immediate release agent, Avicel® PH - 302 ensures robust formulations and consistent performance across diverse pharmaceutical products.

Avicel® RC - 581 consisting of microcrystalline cellulose, is produced using direct compression, dry granulation, and wet granulation technologies. It serves various functions in pharmaceuticals and nutraceuticals, acting as a compression aid, filler, and immediate release agent.

Avicel® RC - 591 is versatile, catering to various dosage forms like lotions, sprays, and suspensions. Its manufacturing technology involves direct compression, dry granulation, and wet granulation methods. In pharmaceutical and nutraceutical applications, it serves as a binder, compression aid, immediate release agent, and stabilizer, ensuring product efficacy and stability.

Avicel® SMCC - 50 is used in tablet formulations, employing various manufacturing technologies like direct compression, dry granulation, and wet granulation. It serves multiple functions in pharmaceutical and nutraceutical applications, including acting as a binder, compression aid, filler, and immediate release agent.

Avicel® SMCC - 90 composed of microcrystalline cellulose, is utilized in various manufacturing technologies, including direct compression, dry granulation, and wet granulation. It serves as both a filler and an immediate release agent in pharmaceutical and nutraceutical applications.

Avicel® SMCC HD 90 comprising non-animal origin microcrystalline cellulose, is utilized in various pharmaceutical and nutraceutical applications. Employing direct compression, dry granulation, and wet granulation manufacturing technologies, it serves as a compression aid, filler, and immediate release agent.